In addition, our results revealed that SNHG5 plays a role in LAD advancement via modulating the epithelial-mesenchymal transition (EMT) of lung cancer tissues, indicating that SNHG5 might be a valuable target in the treatment strategy for LAD. The gene discussed is SNHG5; the disease is lung carcinoma.